The purpose of this study was to observe Efficacy and safety of DWP450 compared with Botox in moderate to severe glabellar line patients.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
268
Chung-Ang University Hospital
Seoul, South Korea
At 4 weeks, Glabellar line improvement rate at maximum frown confirmed with investigator's live severity assessment
At 4 weeks, Glabellar line improvement rate at maximum frown confirmed with investigator's live severity assessment
Time frame: At 4 weeks
At 8, 12, 16 weeks, Glabellar line improvement rate at maximum frown confirmed with investigator's live severity assessment
At 8, 12, 16 weeks, Glabellar line improvement rate at maximum frown confirmed with investigator's live severity assessment
Time frame: At 8, 12, 16 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.